Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 9/2022

Inhalt (33 Artikel)

Review – Cancer Research

Current trends of targeted therapy for oral squamous cell carcinoma

Hongjiao Li, Yao Zhang, Mengmeng Xu, Deqin Yang

Open Access Review – Cancer Research

Effects and duration of exercise-based prehabilitation in surgical therapy of colon and rectal cancer: a systematic review and meta-analysis

Roberto Falz, Christian Bischoff, René Thieme, Johannes Lässing, Matthias Mehdorn, Sigmar Stelzner, Martin Busse, Ines Gockel

Review – Cancer Research

Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression

Rui Liu, Yachun Jia, Guangyao Kong, Aili He

Original Article – Cancer Research

Lymphovascular and perineural invasion are risk factors for inguinal lymph node metastases in men with T1G2 penile cancer

Christian D. Fankhauser, Hielke M. de Vries, Eduard Roussel, Jakob Kristian Jakobsen, Allaudin Issa, Esther W. C. Lee, Nicolo Schifano, Hussain Alnajjar, Fabio Castiglione, Luca Antonelli, Pedro Oliveira, Maurice Lau, Arie Parnham, Maarten Albersen, Nicholas A. Watkin, Asif Muneer, Ben E. Ayres, Oscar R. Brouwer, Vijay Sangar

Open Access Original Article – Cancer Research

Nuclear survivin is a prognosticator in gastroenteropancreatic neuroendocrine neoplasms: a meta-analysis

Sarah Krieg, Christoph Roderburg, Stephen Fung, Tom Luedde, Wolfram Trudo Knoefel, Andreas Krieg

Original Article – Cancer Research

Intratumoral and peritumoral CT-based radiomics strategy reveals distinct subtypes of non-small-cell lung cancer

Xing Tang, Haolin Huang, Peng Du, Lijuan Wang, Hong Yin, Xiaopan Xu

Original Article – Cancer Research

CAR T cells equipped with a fully human scFv targeting Trop2 can be used to treat pancreatic cancer

Hongjia Zhu, Xiaoyan Fang, Israth Jahan Tuhin, Jingwen Tan, Jing Ye, Yujie Jia, Nan Xu, Liqing Kang, Minghao Li, XiaoYan Lou, Jing-e Zhou, Yiting Wang, Zhiqiang Yan, Lei Yu

Open Access Original Article – Cancer Research

R132H IDH1 sensitizes glioma to the antiproliferative and cytotoxic effects of BET inhibition

Thomas K. Sears, Kevin D. Woolard

Open Access Original Article – Cancer Research

Fructose-1,6-bisphosphatase 1 (FBP1) is an independent biomarker associated with a favorable prognosis in esophageal adenocarcinoma

Alexander Damanakis, Patrick Sven Plum, Florian Gebauer, Wolfgang Schröder, Reinhard Büttner, Thomas Zander, Christiane Josephine Bruns, Alexander Quaas

Open Access Original Article – Cancer Research

Inflammation suppresses DLG2 expression decreasing inflammasome formation

Simon Keane, Matthew Herring, Peter Rolny, Yvonne Wettergren, Katarina Ejeskär

Original Article – Cancer Research

Fragmentation of care and colorectal cancer survival in South Korea: comparisons according to treatment at multiple hospitals

Dong-Woo Choi, Seungju Kim, Dong Wook Kim, Kyu-Tae Han

Original Article – Cancer Research

The biological activities of 5,15-diaryl-10,20-dihalogeno porphyrins for photodynamic therapy

Man Yi Li, Le Mi, Gennady Meerovich, Thin Wut Soe, Ting Chen, Ni Ni Than, Yi Jia Yan, Zhi Long Chen

Review – Clinical Oncology

Liquid biopsy: early and accurate diagnosis of brain tumor

Zhenjie Yi, Chunrun Qu, Yu Zeng, Zhixiong Liu

Review – Clinical Oncology

Liposomal formulations for lung cancer treatment in the last two decades: a systematic review

Filipa Canão, Helena Ferreira, Nuno M. Neves

Review – Clinical Oncology

Bidirectional effects of intestinal microbiota and antibiotics: a new strategy for colorectal cancer treatment and prevention

Wenjie Zhang, Jie Zhang, Tian Liu, Juan Xing, Huan Zhang, Daorong Wang, Dong Tang

Original Article – Clinical Oncology

MRI-guided radiotherapy for PVTT in HCC patients: evaluation of the efficacy and safety

So Jung Lee, Myungsoo Kim, Yoo-Kang Kwak, Hye Jin Kang

Open Access Original Article – Clinical Oncology

Predictors for thromboembolism in patients with cholangiocarcinoma

Christian Pfrepper, Maren Knödler, Ruth Maria Schorling, Daniel Seehofer, Sirak Petros, Florian Lordick

Open Access Original Article – Clinical Oncology

The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors

Hana Kim, Soomin Ahn, Hongsik Kim, Jung Yong Hong, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Kyoung-Mee Kim, Seung Tae Kim

Original Article – Clinical Oncology

Early discontinuation of induction therapy in chemoimmunotherapy as an effective alternative to the standard regimen in patients with non-small cell lung cancer: a retrospective study

Kenji Morimoto, Junji Uchino, Takashi Yokoi, Takashi Kijima, Yasuhiro Goto, Akira Nakao, Makoto Hibino, Takayuki Takeda, Hiroyuki Yamaguchi, Chieko Takumi, Masafumi Takeshita, Yusuke Chihara, Takahiro Yamada, Osamu Hiranuma, Yoshie Morimoto, Masahiro Iwasaku, Yoshiko Kaneko, Tadaaki Yamada, Koichi Takayama

Open Access Original Article – Clinical Oncology

Factors influencing patient satisfaction after treatments for early-stage non-small cell lung cancer

Cecilia Pompili, Sanjush Dalmia, Finn McLennan Battleday, Zoe Rogers, Kate Absolom, Hilary Bekker, Kevin Franks, Alex Brunelli, Galina Velikova

Original Article – Clinical Oncology

Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments

Shota Omori, Koji Muramatsu, Takuya Kawata, Eriko Miyawaki, Taichi Miyawaki, Nobuaki Mamesaya, Takahisa Kawamura, Haruki Kobayashi, Kazuhisa Nakashima, Kazushige Wakuda, Akira Ono, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami, Takashi Sugino, Toshiaki Takahashi

Original Article – Clinical Oncology

A comprehensive prognostic analysis of osimertinib treatment in advanced non-small cell lung cancer patients with acquired EGFR-T790M mutation: a real-world study

Xin Tang, Yuan Li, Wen-lei Qian, Wei-feng Yan, Tong Pang, You-ling Gong, Zhi-gang Yang

Open Access Original Article – Clinical Oncology

Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial

Osman Öcal, Daniel Rössler, Antonio Gasbarrini, Thomas Berg, Heinz-Josef Klümpen, Irene Bargellini, Bora Peynircioglu, Otto van Delden, Christian Schulz, Kerstin Schütte, Roberto Iezzi, Maciej Pech, Peter Malfertheiner, Bruno Sangro, Jens Ricke, Max Seidensticker

Open Access Original Article – Clinical Oncology

Non-melanoma skin cancer diagnosis: a comparison between dermoscopic and smartphone images by unified visual and sonification deep learning algorithms

A. Dascalu, B. N. Walker, Y. Oron, E. O. David

Original Article – Clinical Oncology

Impact of preoperative chemotherapy on pathologic nodal status in muscle-invasive bladder cancer: optimal lymphadenectomy in the preoperative chemotherapy era

Wonchul Lee, Wook Nam, Bumjin Lim, Yoon Soo Kyung, Choung-Soo Kim, Hanjong Ahn, Bumsik Hong

Original Article – Clinical Oncology

Clinical study of MAP2K1-mutated Langerhans cell histiocytosis in children

Ying Yang, Chanjuan Wang, Dong Wang, Lei Cui, Na Li, Hongyun Lian, Honghao Ma, Yunze Zhao, Liping Zhang, Wei Liu, Yizhuo Wang, Wanshui Wu, Rui Zhang, Zhigang Li, Tianyou Wang

Original Article – Clinical Oncology

Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients

Sofia Verkhovskaia, Francesca Romana Di Pietro, Simona Mastroeni, Maria Luigia Carbone, Damiano Abeni, Roberto Morese, Francesca Maria Morelli, Stefania D’Atri, Paolo Marchetti, Federica De Galitiis, Cristina Maria Failla, Cristina Fortes

Open Access Original Article – Clinical Oncology

Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy

Regina Mühleck, Sebastian Scholl, Inken Hilgendorf, Karin Schrenk, Jakob Hammersen, Jochen J. Frietsch, Maximilian Fleischmann, Herbert G. Sayer, Anita Glaser, Andreas Hochhaus, Ulf Schnetzke

Open Access Letter to the Editors

Complete and durable response to crizotinib in a patient with malignant pleural mesothelioma harboring CD74-ROS1 fusion

Xuehua Xie, Mengxing You, Erhong Meng, Shunyou Wang, Beifang Niu, Weiming Huang

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.